Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Guoxi Zheng, Zhu Zhu, Kang Zhu, Junrong Wei, Yang Jing & Maoli Duan. (2013) Therapeutic effect of adeno-associated virus (AAV)-mediated ADNF-9 expression on cochlea of kanamycin-deafened guinea pigs. Acta Oto-Laryngologica 133:10, pages 1022-1029.
Read now
Read now
Articles from other publishers (29)
Shaza S. Issa, Alisa A. Shaimardanova, Valeriya V. Solovyeva & Albert A. Rizvanov. (2023) Various AAV Serotypes and Their Applications in Gene Therapy: An Overview. Cells 12:5, pages 785.
Crossref
Crossref
Theresa M. Raimondo & David J. Mooney. (2021) Anti-inflammatory nanoparticles significantly improve muscle function in a murine model of advanced muscular dystrophy. Science Advances 7:26.
Crossref
Crossref
Kirill A. Danilov, Svetlana G. Vassilieva, Anna V. Polikarpova, Anna V. Starikova, Anna A. Shmidt, Ivan I. Galkin, Alexandra A. Tsitrina, Tatiana V. Egorova, Sergei N. Orlov & Yuri V. Kotelevtsev. (2020) In vitro assay for the efficacy assessment of AAV vectors expressing microdystrophin. Experimental Cell Research 392:2, pages 112033.
Crossref
Crossref
Xi Yin, Ying Tang, Jian Li, Anna T. Dzuricky, Chuanqiang Pu, Freddie Fu & Bing Wang. (2017)
Genetic ablation of P65 subunit of NF‐κB in
mdx
mice to improve muscle physiological function
. Muscle & Nerve 56:4, pages 759-767.
Crossref
Crossref
J Huard, X Mu & A Lu. (2016) Evolving paradigms in clinical pharmacology and therapeutics for the treatment of Duchenne muscular dystrophy. Clinical Pharmacology & Therapeutics 100:2, pages 142-146.
Crossref
Crossref
Panicos Shangaris & Anna L. David. 2016. Fetal Stem Cells in Regenerative Medicine. Fetal Stem Cells in Regenerative Medicine
361
402
.
Elizabeth R. Lorden, Howard M. Levinson & Kam W. Leong. (2013) Integration of drug, protein, and gene delivery systems with regenerative medicine. Drug Delivery and Translational Research 5:2, pages 168-186.
Crossref
Crossref
Yuexiang Wang, Adrian Marino-Enriquez, Richard R Bennett, Meijun Zhu, Yiping Shen, Grant Eilers, Jen-Chieh Lee, Joern Henze, Benjamin S Fletcher, Zhizhan Gu, Edward A Fox, Cristina R Antonescu, Christopher D M Fletcher, Xiangqian Guo, Chandrajit P Raut, George D Demetri, Matt van de Rijn, Tamas Ordog, Louis M Kunkel & Jonathan A Fletcher. (2014) Dystrophin is a tumor suppressor in human cancers with myogenic programs. Nature Genetics 46:6, pages 601-606.
Crossref
Crossref
François Monjaret, Nathalie Bourg, Laurence Suel, Carinne Roudaut, Florence Le Roy, Isabelle Richard & Karine Charton. (2014) Cis -splicing and Translation of the Pre- Trans -splicing Molecule Combine With Efficiency in Spliceosome-mediated RNA Trans -splicing. Molecular Therapy 22:6, pages 1176-1187.
Crossref
Crossref
Dwaipayan Sen, Balaji Balakrishnan & Giridhara R. Jayandharan. (2014) Cellular unfolded protein response against viruses used in gene therapy. Frontiers in Microbiology 5.
Crossref
Crossref
Wenjing Zhang, Yang Wang, Shuyun Dong, Rajarshi Choudhury, Yongfeng Jin & Zefeng Wang. (2014) Treatment of Type 1 Myotonic Dystrophy by Engineering Site-specific RNA Endonucleases that Target (CUG) n Repeats. Molecular Therapy 22:2, pages 312-320.
Crossref
Crossref
Sandra L. HarperSira SriswasdiHsin-Yao TangMassimiliano Gaetani, Patrick G. Gallagher & David W. Speicher. (2013) The common hereditary elliptocytosis-associated α-spectrin L260P mutation perturbs erythrocyte membranes by stabilizing spectrin in the closed dimer conformation. Blood 122:17, pages 3045-3053.
Crossref
Crossref
J. J. Magaña, L. Velázquez-Pérez & B. Cisneros. (2012) Spinocerebellar Ataxia Type 2: Clinical Presentation, Molecular Mechanisms, and Therapeutic Perspectives. Molecular Neurobiology 47:1, pages 90-104.
Crossref
Crossref
Christine Rivat, Adrian J. Thrasher & H. Bobby Gaspar. 2013. Clinical Immunology. Clinical Immunology
1054
1065
.
Jonathan D. Proto & Johnny Huard. 2013. Regenerative Medicine and Cell Therapy. Regenerative Medicine and Cell Therapy
113
130
.
Vedanta Mehta & Anna L. David. 2013. Fetal Therapy. Fetal Therapy
417
432
.
Q Yang, Y Tang, K Imbrogno, A Lu, J D Proto, A Chen, F Guo, F H Fu, J Huard & B Wang. (2012) AAV-based shRNA silencing of NF-κB ameliorates muscle pathologies in mdx mice. Gene Therapy 19:12, pages 1196-1204.
Crossref
Crossref
Ingrid E.C. Verhaart & Annemieke Aartsma-Rus. (2012) Gene therapy for Duchenne muscular dystrophy. Current Opinion in Neurology 25:5, pages 588-596.
Crossref
Crossref
Bilal A. Azakir, Sabrina Di Fulvio, Steven Salomon, Marielle Brockhoff, Christian Therrien & Michael Sinnreich. (2012) Modular Dispensability of Dysferlin C2 Domains Reveals Rational Design for Mini-dysferlin Molecules. Journal of Biological Chemistry 287:33, pages 27629-27636.
Crossref
Crossref
Reiko Arakawa, Ryoko Aoki, Masayuki Arakawa & Kayoko Saito. (2012) Human first-trimester chorionic villi have a myogenic potential. Cell and Tissue Research 348:1, pages 189-197.
Crossref
Crossref
Anna L. David & Simon N. Waddington. 2012. Prenatal Gene Therapy. Prenatal Gene Therapy
9
39
.
Dwi U Kemaladewi, Willem MH Hoogaars, Sandra H van Heiningen, Samuel Terlouw, David JJ de Gorter, Johan T den Dunnen, Gert Jan B van Ommen, Annemieke Aartsma-Rus, Peter ten Dijke & Peter AC 't Hoen. (2011) Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy. BMC Medical Genomics 4:1.
Crossref
Crossref
Farhang Alaee, Osamu Sugiyama, Mandeep S Virk, Ying Tang, Bing Wang & Jay R Lieberman. (2011) In vitro evaluation of a double-stranded self-complementary adeno-associated virus type2 vector in bone marrow stromal cells for bone healing. Genetic Vaccines and Therapy 9:1.
Crossref
Crossref
Vedanta Mehta, Khalil Abi Nader, Simon Waddington & Anna L David. (2011) Organ targeted prenatal gene therapy-how far are we?. Prenatal Diagnosis 31:7, pages 720-734.
Crossref
Crossref
Bo Wu, Bin Xiao, Caryn Cloer, Mona Shaban, Arpana Sali, Peijuan Lu, Juan Li, Kanneboyina Nagaraju, Xiao Xiao & Qi Long Lu. (2011) One-year Treatment of Morpholino Antisense Oligomer Improves Skeletal and Cardiac Muscle Functions in Dystrophic mdx Mice. Molecular Therapy 19:3, pages 576-583.
Crossref
Crossref
Jonathan J. Magaña & Bulmaro Cisneros. (2011) Perspectives on gene therapy in myotonic dystrophy type 1. Journal of Neuroscience Research 89:3, pages 275-285.
Crossref
Crossref
Markus A. RüeggDavid J. Glass. (2011) Molecular Mechanisms and Treatment Options for Muscle Wasting Diseases. Annual Review of Pharmacology and Toxicology 51:1, pages 373-395.
Crossref
Crossref
Jana L. Phillips, Julia Hegge, Jon A. Wolff, R. Jude Samulski & Aravind Asokan. 2011. Muscle Gene Therapy. Muscle Gene Therapy
141
151
.
Robert Ng, Lakshmanan Govindasamy, Brittney L. Gurda, Robert McKenna, Olga G. Kozyreva, R. Jude Samulski, Kristin N. Parent, Timothy S. Baker & Mavis Agbandje-McKenna. (2010) Structural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6. Journal of Virology 84:24, pages 12945-12957.
Crossref
Crossref